Corticosteroids are favored postpartum because they effectively treat vitamin D-driven hypercalcemia, do not accumulate in bone, have minimal transfer into breast milk, and are safer for short-term use, including when CYP24A1 abnormalities are present. The gene discussed is CYP24A1; the disease is hypercalcemia disease.